Esomeprazole Magnesium is a drug owned by Dexcel Pharma Technologies Ltd. It is protected by 2 US drug patents filed in 2021 out of which none have expired yet. Based on its patents and exclusivities, its generic launch date is estimated to be Dec 08, 2036. Details of Esomeprazole Magnesium's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US10076494 | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(12 years from now) | Active |
| US10835488 | Stable orally disintegrating pharmaceutical compositions |
Dec, 2036
(12 years from now) | Active |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Esomeprazole Magnesium's patents.
Latest Legal Activities on Esomeprazole Magnesium's Patents
Given below is the list of recent legal activities going on the following patents of Esomeprazole Magnesium.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 May, 2024 | US10835488 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Feb, 2022 | US10076494 |
| Recordation of Patent Grant Mailed Critical | 17 Nov, 2020 | US10835488 |
| Patent Issue Date Used in PTA Calculation Critical | 17 Nov, 2020 | US10835488 |
| Email Notification Critical | 29 Oct, 2020 | US10835488 |
| Issue Notification Mailed Critical | 28 Oct, 2020 | US10835488 |
| Email Notification Critical | 13 Oct, 2020 | US10835488 |
| Mailing Corrected Notice of Allowability | 13 Oct, 2020 | US10835488 |
| Dispatch to FDC | 10 Oct, 2020 | US10835488 |
| Corrected Notice of Allowability | 07 Oct, 2020 | US10835488 |
US patents provide insights into the exclusivity only within the United States, but Esomeprazole Magnesium is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Esomeprazole Magnesium's family patents as well as insights into ongoing legal events on those patents.
Esomeprazole Magnesium's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Esomeprazole Magnesium's generic launch date based on the expiry of its last outstanding patent is estimated to be Dec 08, 2036 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Esomeprazole Magnesium Generic API suppliers:
Esomeprazole Magnesium is the generic name for the brand Esomeprazole Magnesium. 30 different companies have already filed for the generic of Esomeprazole Magnesium, with Hetero Labs Ltd Iii having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Esomeprazole Magnesium's generic
Alternative Brands for Esomeprazole Magnesium
There are several other brand drugs using the same active ingredient (Esomeprazole Magnesium) as Esomeprazole Magnesium. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |
|---|---|---|
| Astrazeneca |
| |
| Astrazeneca Lp |
| |
| Horizon |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Esomeprazole Magnesium, Esomeprazole Magnesium's active ingredient. Check the complete list of approved generic manufacturers for Esomeprazole Magnesium
About Esomeprazole Magnesium
Esomeprazole Magnesium is a drug owned by Dexcel Pharma Technologies Ltd. Esomeprazole Magnesium uses Esomeprazole Magnesium as an active ingredient. Esomeprazole Magnesium was launched by Dexcel in 2020.
Approval Date:
Esomeprazole Magnesium was approved by FDA for market use on 20 October, 2020.
Active Ingredient:
Esomeprazole Magnesium uses Esomeprazole Magnesium as the active ingredient. Check out other Drugs and Companies using Esomeprazole Magnesium ingredient
Dosage:
Esomeprazole Magnesium is available in tablet, orally disintegrating, delayed release form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| EQ 20MG BASE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | Discontinued | ORAL |